Saturday, September 23, 2023
Saturday, September 23, 2023

Heather Richards Appointed Chief Revenue Optimization Officer at Atlas Healthcare Partners

Heather Richards will lead all revenue strategy and revenue cycle management.

Heather Richards will oversee revenue cycle teams and operations that directly impact patients and physicians, as well as the finances of Atlas’s managed ASCs and its health system partners. She also will lead traditional managed care reimbursement strategy and contracting with Banner Health as well as new health system partners.

“Having known Heather for many years, I am confident in her leadership and expertise as an innovator in healthcare,” said Atlas Healthcare Partners CEO Aric Burke. “Her experience is vital to Atlas, given how rapidly payment models are shifting from fee-for-service provider payments to value-based care payment models. We are excited to have her on our executive leadership team.”

Prior to Atlas, Heather Richards was the Senior Vice President of Value-Based Care Initiatives for MPOWERHealth, where she designed and implemented a specialty Clinically Integrated Network (CIN) of musculoskeletal surgeons across eight states, which included the supporting management organization and the group purchasing organization (GPO) structure. She led the recruitment of 300+ specialty physicians to participate in value-based network opportunities including the CIN and other value-based payment model programs. She also launched the company’s first commercial bundled payment program for spine and total joint procedures including the program’s incentive design, operational structure and payer value proposition.

Prior to MPOWER, Heather Richards was Vice President of Revenue Cycle Management and Business Office Oper

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

MORE EXECUTIVES

Carthera Appoints Dr Oern Stuge as Chairman of Board of Directors

Dr Oern Stuge brings 30+ years expertise with a wealth of experience in product development and commercial launches to support Carthera’s future growth.

Cytomos Appoints a New Director as £4 Mill Investment Sets Path for Commercialisation of Groundbreaking Cell Analysis Technology

The biotech company’s appointment of industry leader Dr Sharon Brownlow as Non-Executive Director further enhances Cytomos’ senior management team and its unique value proposition to key industry markets.

Kindeva Drug Delivery Appoints Brian Schubmehl as Chief Human Resources Officer

Brian Schubmehl brings more than two decades of diverse and senior global leadership expertise that has spanned private equity, startup, and publicly traded organizations.

Joseph Schwab MD, MS, to Lead Spine-Oncology Program and Center for Surgical Technology and AI Research at Cedars-Sinai

Joseph Schwab combines extensive experience in translational research and clinical trials with a record of high-quality clinical care. He specializes in the management of benign and malignant bone tumors as well as spinal disorders, including stenoses and myelopathy. His expertise will drive transformative advancements in spine oncology and surgical technology at Cedars-Sinai.

Perimeter Medical Imaging AI Strengthens Leadership Team with Appointment of Experienced MedTech Executive, Adam Hodges, as Vice President, Sales and Marketing

Adam Hodges brings more than 20 years of commercialization experience in the medical device industry. Most recently, Adam was Vice President of Sales at SIA Health, leading the commercial acceleration of DuraSorb®, which was acquired by Integra LifeSciences (NASDAQ: IART) in December 2022. During his tenure at SIA, Adam grew sales revenue by more than 5X in less than two years and previously served concurrent roles of Vice President of Strategic Accounts and Regional Business Director.

By using this website you agree to accept Medical Device News Magazine Privacy Policy